The agreement provides Neuromed with the exclusive rights to sell in Chile and includes minimum purchase requirements.
The SonaStar is used by Neuro and General Surgeons for quick and efficient removal of both hard and soft tumors while sparing most vessels. In addition, OsteoSculpt bone sculpting technology can be employed with the SonaStar to safely remove osseous structures, thus providing access to the surgical site.
The BoneScalpel is a tissue specific osteotomy device capable of making precise cuts through bone and hard tissue while largely preserving delicate soft tissue structures. It offers the convenience and speed of a power instrument without the danger associated with rotary sharps.
Michael McManus, president and chief executive officer of Misonix, said: “Misonix is pleased to add Neuromed Chile to our family of Latin American specialty distributors, a geographic area that is receiving a focused effort from our Sales and Marketing team. We are particularly pleased that they will be distributing two of our key products through their well established surgical products organization.”
